Loading...

Alimera Sciences, Inc.

ALIMNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.54
$-0.01(-0.18%)

Alimera Sciences, Inc. (ALIM) Stock Overview

Explore Alimera Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.6/100

Key Financials

Market Cap301.3M
P/E Ratio-22.58
EPS (TTM)$1.05
ROE-0.32%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$1.76

ALIM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alimera Sciences, Inc. (ALIM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.76.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.58 and a market capitalization of 301.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;